The Efficacy of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patients of African American and Hispanic Origin: A Randomized Clinical Trial

BACKGROUND: The study was initiated in 2020 to test the efficacy of a nitric oxide generating lozenge (NOL) in outpatients with newly diagnosed COVID-19 to mitigate disease severity. The study enrolled high risk patients, African American and Latino. METHODS: This was a randomized, double blinded, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bryan, Nathan S., Molnar, Janos, Somberg, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Clinical Research Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290177/
https://www.ncbi.nlm.nih.gov/pubmed/37356641
http://dx.doi.org/10.1016/j.amjmed.2023.05.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290177/
https://www.ncbi.nlm.nih.gov/pubmed/37356641
http://dx.doi.org/10.1016/j.amjmed.2023.05.021

Ejemplares similares